ISSN: 2574-187X
Authors: Sheeba S* , Murugan M and Suman Sankar AS
The recent coronavirus 2019 (COVID-19) outbreak was caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2). Finding newer therapeutic targets is necessary because, despite the fact that pandemics like SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV) have been around for almost 20 years, no effective medication against the CoV family has been approved. Compared to conventional PCR tests, nanoparticle-based biosensors and point-of-care testing kits yield faster and more accurate issues with toxicity. In order to successfully incorporate nanotechnology into standard medical practice and improve readiness for upcoming pandemics, several problems must be resolved. With an emphasis on medication administration, diagnostics, vaccinations, and protective gear, this study investigates several nanotechnology-based strategies for COVID-19 management. Engineered nanoparticles (NPs) are used in Nano medicine to improve immunological response, targeting, and medication stability while lowering toxicity. The research emphasizes how important Nano medicine is in the fight against COVID-19 by improving drug delivery, diagnostics, vaccinations, and protective gear. The findings show that, in comparison to traditional methods, nanotechnology offers better efficacy, tailored distribution, and fewer adverse effects. To assurance the wellbeing, effectiveness, and moral application of Nano medicine in healthcare, stringent regulations are required.
Keywords: Covid 19; Homoeopathy; Nano Medicine; Nanoparticles; Vaccination
Chat with us on WhatsApp